Tessara Therapeutics Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Accelerator/Inc
- Latest Deal Amount
-
$3M
- Investors
-
2
Tessara Therapeutics General Information
Description
Developer of three-dimensional (3D) neural micro-tissues intended for therapeutic and drug screening applications. The company aims to replace inadequate and expensive existing cell and animal models and its micro-tissues are designed to secrete therapeutic factors to address key deficiencies associated with Parkinson's disease pathophysiology and other neurological diseases, enabling the medical community to reduce costs and failures in neuroscience drug development to date.
Contact Information
Website
www.tessaratherapeutics.comCorporate Office
- 40 City Road
- Southbank
- Melbourne, Victoria 3006
- Australia
Corporate Office
- 40 City Road
- Southbank
- Melbourne, Victoria 3006
- Australia
Tessara Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Accelerator/Incubator | 01-Dec-2024 | $3M | Completed | Generating Revenue | ||
| 2. Angel (individual) | 28-Mar-2022 | Completed | Generating Revenue | |||
| 1. Angel (individual) | 07-May-2020 | $2.7M | $2.7M | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Tessara Therapeutics Patents
Tessara Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2026908645-A0 | Improved cellularised hydrogel compositions and related methods | Pending | 16-Oct-2026 | ||
| AU-2025904886-A0 | Improved cellularised hydrogel compositions and related methods | Pending | 17-Oct-2025 | ||
| AU-2025900783-A0 | Integrated biosensor compositions and methods | Inactive | 13-Mar-2025 | ||
| AU-2024903364-A0 | Improved cellularised hydrogel compositions and related methods | Pending | 18-Oct-2024 | ||
| AU-2024900695-A0 | Integrated biosensor compositions and methods | Pending | 15-Mar-2024 |
Tessara Therapeutics Signals
Tessara Therapeutics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cicada Innovations | Accelerator/Incubator | |||
| Jumar Bioincubator | Accelerator/Incubator |
Tessara Therapeutics FAQs
-
When was Tessara Therapeutics founded?
Tessara Therapeutics was founded in 2018.
-
Where is Tessara Therapeutics headquartered?
Tessara Therapeutics is headquartered in Melbourne, Australia.
-
What is the size of Tessara Therapeutics?
Tessara Therapeutics has 10 total employees.
-
What industry is Tessara Therapeutics in?
Tessara Therapeutics’s primary industry is Discovery Tools (Healthcare).
-
Is Tessara Therapeutics a private or public company?
Tessara Therapeutics is a Private company.
-
What is Tessara Therapeutics’s current revenue?
The current revenue for Tessara Therapeutics is .
-
How much funding has Tessara Therapeutics raised over time?
Tessara Therapeutics has raised $15.7M.
-
Who are Tessara Therapeutics’s investors?
Cicada Innovations and Jumar Bioincubator have invested in Tessara Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process